Jiuzhitang Co., Ltd. (SZSE: 000989)
Health Care · Pharmaceuticals · CN
CN¥8.91
+1.83% today · -8.6% 1Y
Jiuzhitang Co., Ltd. (SZSE: 000989) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.13B and employs 3,674 people.
Over the last twelve months the share price has lost 8.6%, trading between 7.40 and 10.84.
Tweenvest scores Jiuzhitang Co., Ltd. across four factors: quality 73/100, value 72/100, growth 31/100, dividend 100/100. Its strongest factor is dividend.
000989 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.13B
- Revenue (TTM)
- $382.32M
- P/E
- 22.92
- EPS
- 0.39
- Dividend yield
- 3.37%
- Beta (5Y)
- 0.13
- 52-week high
- CN¥10.84
- 52-week low
- CN¥7.40
- Avg volume (3M)
- —
- Shares outstanding
- 846.28M
- Employees
- 3,674
- Next earnings
- —
About Jiuzhitang Co., Ltd.
Jiuzhitang Co., Ltd. is a Chinese pharmaceutical company specializing in the development and distribution of traditional Chinese, chemical, biological, and health-related medicinal products. Its product portfolio addresses a wide array of health concerns. For instance, cardiovascular and cerebrovascular conditions are treated with offerings like shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria. Gynecological issues are targeted by Guizhi Fuling pills, Buxue Shengru granules, and other hemostasis and analgesic preparations. Respiratory ailments can be managed with Schicon, while digestive disorders benefit from products such as Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products. Furthermore, the company supplies a comprehensive range of over-the-counter (OTC) medications. These non-prescription drugs support areas including qi and blood nourishment, cardiovascular and cerebrovascular health, urinary system function, pediatric care, women's health, musculoskeletal wellness, respiratory relief, dermatological conditions, nervous system support, ENT treatments, digestive aid, and even tumor-related concerns. Established in Beijing, China, in 1999, Jiuzhitang Co., Ltd. maintains its headquarters there.
- ISIN
- CNE000001394
- Founded
- 1999
- Listed since
- Jun 28, 2000
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Tianyu Pharmaceutical Co., Ltd.SZSE: 300702 | $1.14B | CN¥22.18 | -2.20% |
| Tianjin Ringpu Bio-Technology Co.,Ltd.SZSE: 300119 | $1.14B | CN¥16.81 | +0.30% |
| Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176 | $1.14B | CN¥13.47 | -7.74% |
| Amphastar Pharmaceuticals, Inc.NasdaqGS: AMPH | $1.13B | $26.62 | +3.14% |
| Towa Pharmaceutical Co., Ltd.TSE: 4553 | $1.13B | ¥3,620.00 | +3.58% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.13B | CN¥36.80 | -6.60% |
| Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553 | $1.10B | CN¥11.85 | -7.78% |
| Harrow, Inc.NasdaqGM: HROW | $1.10B | $29.36 | -3.80% |
Figures last refreshed Oct 11, 2026.